Oragenics

$0.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0254 (-2.86%) Today
-$0.0023 (-0.27%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Oragenics and other stocks, options, and ETFs commission-free!

About OGEN

Oragenics Inc., also called Oragenics, is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains.

CEO
Alan F. Joslyn
Employees
7
Headquarters
Tampa, Florida
Founded
1996
Market Cap
92.08M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.16M
High Today
$0.88
Low Today
$0.846
Open Price
$0.8705
Volume
1.51M
52 Week High
$2.09
52 Week Low
$0.36

OGEN Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

FGEN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure